Article
Pirbright joins European African Swine Fever Project
The Pirbright Institute has joined a European Union-funded project which will study next-generation vaccines against African swine fever (ASF). Backed by support from Horizon Europe and led by the biotechnological pharmaceutical company, HIPRA, the four-year VAX4ASF project…
Read more